JPMorgan Upgrades Science Applications International Corp
In a significant move, JPMorgan has recently upgraded Science Applications International Corp (NASDAQ:SAIC) from a Neutral rating to an Overweight rating. This upgrade reflects the firm’s growing confidence in the company's potential, raising its price target from $150.00 to an impressive $170.00. This optimistic view comes on the heels of Science Applications' strategic initiatives aimed at transitioning to higher-value services, a message strongly conveyed during their Investor Day earlier this year.
Strengthening Financial Performance
Science Applications International Corp has showcased a robust trajectory of financial growth, illustrated by a significant increase in their qualified pipeline, which has grown from approximately $115 billion in FY24 to around $130 billion currently. The company has also ramped up its submitted bids, showcasing a remarkable rise from $17 billion last year to an impressive $22 billion this year. Notably, in the first half alone, they submitted nearly $15 billion in bids, surpassing their internal goals.
Aiming for Ambitious Growth Targets
The company's leadership has set ambitious performance metrics, aiming for a new business win rate exceeding 30% and a retention rate between 80% and 90% for re-competes. By targeting these metrics, they anticipate achieving a trailing 12-month book-to-bill ratio of 1.2x by the middle of FY26. Although the company faces challenges relating to lost re-compete opportunities, affecting organic growth by about five percentage points this fiscal year, they project that these issues will diminish as they proceed into FY26.
Projected Growth and Margin Expansion
In their forecasts for FY26, Science Applications is anticipating a growth rate of 3%, coupled with a modest margin expansion of 10 basis points. JPMorgan views these projections as realistic, especially considering the potential for additional gains linked to the company's adeptness in pursuing new programs. Despite some risks associated with securing new contracts and the complexities of enhanced technical requirements, analysts indicate that there is a possibility for improved margin rates ahead.
Valuation Insights from JPMorgan
JPMorgan's analysis suggests that existing market valuations may reflect skepticism surrounding SAIC’s performance. However, the firm underscores the strong free cash flow that SAIC generates, over $500 million annually, which translates to about 7% of the company's current market capitalization. The commitment of management to return this cash to shareholders underpins a positive outlook moving forward. The targeted price of $170 by December 2025 is calculated on 16 times the estimate for adjusted EPS for FY27 (CY26).
Recent Contracts and Market Ventures
In other developments, Science Applications has been actively engaging in securing new contracts. Recently, they finalized a $229 million deal with the U.S. Department of Defense, which aims to bolster the IT capabilities of NORAD and USNORTHCOM. Furthermore, their latest fiscal quarter performance revealed a 2% increase in revenue, although EBITDA saw a 2% decline. Nevertheless, their results surpassed market expectations and led to revised forecasts for FY2025, predicting a revenue growth of 3% and an EBITDA growth of 4%.
Continued Growth and Shareholder Commitment
Science Applications is aligning its business strategies with key growth areas and improving its bidding capabilities. The ambition is to achieve a book-to-bill ratio of 1.2x by the first half of FY26, alongside a target for 5% organic revenue growth by the end of the same fiscal year. While acknowledging potential risks tied to the procurement process and external market factors, company executives remain confident in their strategic direction aimed at driving sustainable growth.
Insights from Recent Market Data
Further supporting JPMorgan's positive outlook, recent data indicates that Science Applications International Corp holds a market capitalization of $6.97 billion, with a P/E ratio standing at 25.12, signaling robust investor confidence in the firm’s earnings potential. The revenue for the past twelve months as of Q2 2025 reached $7.297 billion, accompanied by a gross profit margin of 11.57%, reflecting opportunities for further improvement aligned with their focus on value-centered work.
Commitment to Shareholders
The firm has maintained consistent dividend payments for an impressive 12 years, showcasing a dedicated approach to shareholder value. This commitment resonates with JPMorgan's observations of SAIC's strong free cash flow and management's emphasis on returning value to shareholders. Notably, aggressive share buyback initiatives by the management are poised to enhance earnings per share and support stock price stability.
Performance Metrics and Investor Considerations
The stock has illustrated commendable returns, recording a total price return of 21.26% over the past three months, and an even more impressive return of 33.28% year-over-year. This positive momentum reinforces JPMorgan's upgraded stance and elevated price target. However, potential investors should remain vigilant as technical indicators like the RSI suggest that the stock may currently be overbought, signaling a possible short-term retracement.
Frequently Asked Questions
What recent changes did JPMorgan make regarding SAIC's stock rating?
JPMorgan upgraded Science Applications' stock from Neutral to Overweight and raised its price target to $170.00.
What factors contributed to SAIC's recent financial performance?
SAIC's financial performance has significantly improved due to a strategic focus on high-value work and a robust increase in submitted bids.
How much is SAIC's qualified pipeline currently worth?
SAIC's qualified pipeline has expanded to approximately $130 billion.
What is the anticipated growth rate for SAIC in FY26?
Science Applications International Corp projects a 3% growth rate for FY26.
How has SAIC performed in terms of shareholder returns?
SAIC has consistently paid dividends for 12 consecutive years and has engaged in aggressive share buybacks to enhance shareholder value.
